COVID-19 Breath Test Developed at Technion Detects Disease With 92% Accuracy in Study

A breathalyzer device developed by Professor Hossam Haick of the Wolfson Faculty of Chemical Engineering at Technion and Dr. Yoav Broza of the Technion’s Russel Berrie Nanotechnology Institute has been successful differentiating between positive and negative COVID19 patients 92% of the time in a new Trial. This non-invasive rapid testing technique would be a major improvement over current testing methods that must be sent to a lab for analysis and can take up to a week to return results. This technology will be developed commercially by Nanose Medical, were Haick is the CTO. Nanose was founded based on a breathalyzer device developed by Professors Haick and Nir Peled of Tel Aviv University’s Sackler School of Medicine which was able to detect cancers and other diseases. In 2018 Dr. Haick won the EU Innovation Award for his research on using breath tests to detect diseases.

https://nocamels.com/2020/08/covid-19-breath-test-92-accuracy-trial/

Written by:

Noam Kaplan

Engagement Chair, TFI